What is VaxPro?
VaxPro specializes in delivering comprehensive on-site vaccination services, encompassing flu shots, COVID-19 immunizations, tuberculosis testing, and biometric screenings. With over two decades of operational experience, the company serves a broad clientele, including corporate entities, educational institutions, senior living facilities, healthcare providers, and community gatherings across the United States. VaxPro is recognized for its efficient, insured, and HIPAA-compliant service model, prioritizing both convenience and the advancement of public health. Their core mission revolves around simplifying health management for organizations by providing continuous support and accessible personal health insights.
How much funding has VaxPro raised?
VaxPro has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in VaxPro
PPP
Public-Private Partnership
What's next for VaxPro?
The recent substantial expansion capital positions VaxPro for significant scaling and strategic development. As a company operating at a Series B/C stage, this investment is likely earmarked for enhancing operational infrastructure, expanding geographic coverage, and potentially developing new service lines or technological integrations to further streamline their on-site health solutions. The focus on public health and corporate wellness indicates a strong market demand, suggesting VaxPro will continue to solidify its presence as a leader in accessible healthcare services.
See full VaxPro company page
